Avid Bioservices Inc (CDMO)

[swg_tdr]

MH, best-ever SUMMARY-- now as to cash burn and given your call for a fully built-out mfg capability to support a massive Bavi demand (vertical sales after approval)

do we not need a CP 50/50 participation partner?

or, given this Mickey Mouse share price, do we not require a big name investment banker and a properly hyped secondary offering?

any comments by RRdog and other heavy hitters re

Reliance on a cash sidestream from manufacturing, while keeping one's manufacturing capacity and acumen in sharp shape, is not the same as preparing to become a 'manufacturing' company in case the primary business objective doesn't come through. That's never been the intent and, with recent development, it definitely isn't the trend going forward.

Post Finally... there will be serious cash bleeding until a deal takes place - but it's not based on some random decision making or loose respect for cash burn. From all indications - Peregrine is going ultra aggressive on positioning for the next wave in Oncology evolution by introducing a molecule with broad range combination synergy across treatment modalities. Notice the pre-work with the FDA on trial design for the Breast P II. Notice the early data readouts of less than 12 months from trial start for indications such as Breast that traditionally take 18-24 months. Money will burn and it's for a great cause. They're aiming to come in with an overwhelming set of results that will instantly establish this method of treatment as an anchor.

thanks and best,
N